关键词：医药市场；营销模式；医疗保健基础设施；新兴医药市场
摘 要：The emerging market for pharmaceutical products is termed as pharmerging. The Global Pharmaceutical market is witnessing a paradigm shift in the marketing of pharmaceutical products from the saturated developed regions to the developing regions, owing to an increased accessibility toward quality healthcare infrastructure supported by funds and investment from the government and private companies. These developing regions are referred to as the Pharmerging markets. Further, big pharmaceutical manufacturers are currently facing a decline in the sales of their products owing to a patent cliff leading to tough competition from generic drug manufacturers. As of 2012, the Pharmerging markets represent 20 percent of the Global Pharmaceutical market and are expected to represent 50 percent of the Global Pharmaceutical market by 2020.
目 录：

01. Executive Summary

02. Scope of the Report

02.1 Market Overview

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviation

05. Introduction

05.1 Market Overview

06. Market Landscape

06.1 Global Pharmaceutical Market

06.1.1 Market Size and Forecast

06.1.2 Global Pharmaceutical Market

06.2 Pharmerging Markets

06.2.1 Market Size and Forecast

06.2.2 Pharmaceutical Spending in Pharmerging Markets

06.3 Five Forces Analysis

07. Market Segmentation by Geographical Regions

07.1 Pharmerging Markets Segmentation by Country  

07.2 Revenue Generation of Pharmerging Markets by Country

07.2.1 Pharmerging Markets Share by Country

08. Market Overview of Tier 1 Country

08.1 Pharmaceutical Market in China

08.1.1 Market Size and Forecast

09. Market Overview of Tier 2 Country

09.1 Pharmaceutical Market in Brazil

09.1.1 Market Size and Forecast

09.2 Pharmaceutical Market in Russia

09.2.1 Market Size and Forecast

09.3 Pharmaceutical Market in India

09.3.1 Market Size and Forecast

10. Market Overview of Tier 3 Country

10.1 Pharmaceutical Market in Mexico

10.1.1 Market Size and Forecast

10.2 Pharmaceutical Market in Turkey

10.2.1 Market Size and Forecast

10.3 Pharmaceutical Market in Poland

10.3.1 Market Size and Forecast

10.4 Pharmaceutical Market in Indonesia

10.4.1 Market Size and Forecast

10.5 Pharmaceutical Market in Other Pharmerging Regions

10.5.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Acquisitions

18.2 Top Pharmaceutical Companies in the Pharmerging Markets

19. Key Vendor Analysis

19.1 Eli Lilly and Co

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 GlaxoSmithKline plc

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Key Information

19.2.4 SWOT Analysis

19.3 Johnson & Johnson

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information

19.3.4 SWOT Analysis

19.4 Merck & Co. Inc.

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 SWOT Analysis

19.5 Novartis International AG

19.5.1 Business Overview

19.5.2 Business Segmentation

19.5.3 Key Information

19.5.4 SWOT Analysis

19.6 Pfizer Inc.

19.6.1 Business Overview

19.6.2 Business Segmentation

19.6.3 Key Information

19.6.4 SWOT Analysis

20. Other Reports in this Series